Design and fabrication of a 5-fluorouracil-based nanocarrier containing carboxymethyl cellulose/ riboflavin/ carbon nanotubes for delivery to MCF-7 cancer cells
Year: 2026
Type: article
Abstract: The primary objective of this research is to develop a highly stable, biocompatible nanocomposite for pH-responsive, controlled delivery of 5-fluorouracil (5-FU) to enhance its therapeutic performance. In this study, a carboxymethyl cellulose (CMC)/ riboflavin (RF) /carbon nanotubes (CNTs)-based nanocomposite was synthesized using the water/oil/water (W/O/W) double emulsion method with the aid of sweet almond oil and the surfactant Span 80, for controlled delivery of the drug 5-FU. Fourier-transform infrared spectroscopy (FTIR) was used to examine the functional groups of the nanocomposite components, and X-ray diffraction (XRD) was used to study the crystal structure. To determine the morphology, a field-emission scanning electron microscope (FE-SEM) was used, which confirmed the core-shell structure of the nanocarriers with a hemispherical shape. Dynamic light scattering (DLS) was used to determine the particle size, which was reported to be 236.7 nm. Analysis of zeta potential showed a value of −89.77 ± 3.20 mV, indicating a highly stable colloidal structure. The drug loading efficiency (LE) was 45.25%, and the encapsulation efficiency (EE) was 87%. Over a 96-hour period, the drug-loaded nanocarrier exhibited a strictly pH-dependent behavior, with cumulative drug release reaching a maximum of 91% in the acidic tumor environment (pH 5.4) versus 75% in the neutral healthy tissue medium (pH 7.4). The drug release mechanism was investigated by fitting experimental data to different kinetic models. The release patterns of 5-FU in the nanocomposite under neutral and acidic conditions followed the Hixson-Crowell ( 𝑅 2 = 0 . 9 9 7 2 ) and Korsmeyer–Peppas ( 𝑅 2 = 0 . 9 6 1 9 ) kinetic models, respectively. The MTT assay was performed to assess cell viability and cytotoxicity, revealing that the CNTs/CMC/RF@5-FU nanocarrier exhibited significant cytotoxicity against breast cancer cells, successfully reducing MCF-7 cell viability to 35.45% compared to 50.51% for the free drug.
Source: Next Nanotechnology
Authors: Mobina Momeni(Data curation, Formal analysis, Investigation, Resources, Software, Writing – original draft), Mehrab Pourmadadi(Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Fatemeh Yazdian(Data curation, Funding acquisition, Investigation, Resources, Supervision, Validation, Visualization, Writing – review & editing), Nassrin Qavami(Data curation, Methodology, Resources), Hamid Rashedi(Data curation, Formal analysis, Resources, Writing – review & editing)
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Keywords: 5-fluorouracil, nanocarriers, carboxymethyl cellulose, riboflavin, carbon nanotubes, pH-responsive drug delivery, controlled drug release, breast cancer, MCF-7 cells, core-shell nanocomposites, water-in-oil-in-water emulsion, drug loading and encapsulation efficiency, release kinetics, cytotoxicity, bionanocomposites
Open Access status: gold
Estimated APC paid: $1,280
OpenAlex ID: W7235612381
